Structure Therapeutics
GPCR
160 hedge funds and large institutions have $2.69B invested in Structure Therapeutics in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 69 increasing their positions, 35 reducing their positions, and 33 closing their positions.
97% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 35
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
16% more capital invested
Capital invested by funds: $2.33B → $2.69B (+$361M)
12% more call options, than puts
Call options by funds: $20.8M | Put options by funds: $18.6M
1.17% more ownership
Funds ownership: 34.64% → 35.81% (+1.2%)
4% less funds holding
Funds holding: 166 → 160 (-6)
18% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$33.7M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$26.7M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$23.3M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$22.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$37.2M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$27.1M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$24.9M |
| 4 |
MCC
Money Concepts Capital
Palm Beach Gardens,
Florida
|
-$14.7M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$12.7M |
GPCR Hedge Fund Activity: Q3 2024 in Review
160 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Structure Therapeutics (GPCR) for Q3 2024, worth a combined $2.69B — up 16% from $2.33B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of GPCR and 27 opened new positions — a net loss of 6 holders — while 35 trimmed existing stakes and 69 added.
The largest buyer was Point72 Asset Management, adding an estimated $33.7M. The largest seller was Adage Capital Partners, cutting an estimated $37.2M.
- 160 institutional investors held Structure Therapeutics (GPCR) as of Q3 2024, down from 166 in Q2 2024.
- Funds reported $2.69B of Structure Therapeutics stock for Q3 2024, up 16% quarter-over-quarter.
- 27 funds opened new Structure Therapeutics positions in Q3 2024 and 33 closed out, a net change of -6 holders.
- The largest Structure Therapeutics buyer in Q3 2024 was Point72 Asset Management, an estimated $33.7M added.
- The largest Structure Therapeutics seller in Q3 2024 was Adage Capital Partners, an estimated $37.2M sold.
Based on aggregated 13F filings for Q3 2024.